See up to 3 months of OM. The 7-day demo opens the 1M and 3M ranges and puts OM on your watchlist.
Start 7-day demoLatest OM insider trades
About Outset Medical, Inc. (OM)
The SEC lists Outset Medical, Inc. under CIK 0001484612, in electromedical and electrotherapeutic apparatus. We track it alongside the rest of the Health Care sector.
OM Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 2 | 244,909 | $870K |
| Open-market sale | 3 | 10,612 | $47K |
OM insider transactions (Form 4)
3544 Form 4 filings on record, the earliest from Nov 18, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Braden Michael Leonard - 10% Owner | Open-market purchase | Common Stock | 228,334 | $3.53 footnote F2 | $806K | |
| Braden Michael Leonard - 10% Owner | Open-market purchase | Common Stock | 16,575 | $3.88 footnote F3 | $64K | |
| ||||||
 Leslie Trigg - Officer | Open-market sale | Common Stock | 3,437 footnote F1 | $4.39 | $15K | |
| ||||||
| John L. Brottem - Officer | Open-market sale | Common Stock | 2,632 footnote F1 | $4.39 | $12K | |
| ||||||
| Renee Gaeta - Officer | Open-market sale | Common Stock | 4,543 footnote F1 | $4.39 | $20K | |
| ||||||
| John L. Brottem - Officer | Grant or award | Common Stock | 59,830 footnote F1 | $0.00 | - | |
| ||||||
| Renee Gaeta - Officer | Grant or award | Common Stock | 71,630 footnote F1 | $0.00 | - | |
| ||||||
| Leslie Trigg - Officer | Grant or award | Common Stock | 99,160 footnote F1 | $0.00 | - | |
| ||||||
| Patrick T. Hackett - Director | Grant or award | Common Stock | 10,667 footnote F1 | $0.00 | - | |
| ||||||
 Kevin C. Oboyle - Director | Grant or award | Common Stock | 10,667 footnote F1 | $0.00 | - | |
| ||||||
| Karen Prange - Director | Grant or award | Common Stock | 10,667 footnote F1 | $0.00 | - | |
| ||||||
| Brent D. Lang - Director | Grant or award | Common Stock | 10,667 footnote F1 | $0.00 | - | |
| ||||||
| D. Keith Grossman - Director | Grant or award | Common Stock | 10,667 footnote F1 | $0.00 | - | |
| ||||||
| Karen Drexler - Director | Grant or award | Common Stock | 10,667 footnote F1 | $0.00 | - | |
| ||||||
| Renee Gaeta - Officer | Open-market sale | Common Stock | 17,672 footnote F1 | $4.94 | $87K | |
| ||||||
| Leslie Trigg - Officer | Open-market sale | Common Stock | 3,445 footnote F1 | $3.70 | $13K | |
| ||||||
| Marc Nash - Officer | Open-market sale | Common Stock | 1,582 footnote F1 | $3.70 | $6K | |
| ||||||
| John L. Brottem - Officer | Open-market sale | Common Stock | 2,638 footnote F1 | $3.70 | $10K | |
| ||||||
| Braden Michael Leonard | Other | Common Stock | 323,000 | $5.00 | $1.61M | |
| Braden Michael Leonard | Other | Common Stock | 197,600 | $5.00 | $988K | |
| Braden Michael Leonard | Other | Common Stock | 96,900 | $5.00 | $485K | |
| Derick A. Elliott - Officer | Grant or award | Common Stock | 96,000 footnote F1 | $0.00 | - | |
| ||||||
| John L. Brottem - Officer | Open-market sale | Common Stock | 2,842 footnote F1 | $3.35 | $10K | |
| ||||||
| Leslie Trigg - Officer | Open-market sale | Common Stock | 3,361 footnote F1 | $3.35 | $11K | |
| ||||||
| Marc Nash - Officer | Open-market sale | Common Stock | 1,817 footnote F1 | $3.35 | $6K | |
| ||||||
| Marc Nash - Officer | Open-market sale | Common Stock | 5,375 footnote F1 | $5.12 | $28K | |
| Marc Nash - Officer | Open-market sale | Common Stock | 980 footnote F1 | $4.98 | $5K | |
| ||||||
| John L. Brottem - Officer | Open-market sale | Common Stock | 9,314 footnote F1 | $5.12 | $48K | |
| John L. Brottem - Officer | Open-market sale | Common Stock | 1,180 footnote F1 | $5.01 | $6K | |
| ||||||
| Leslie Trigg - Officer | Open-market sale | Common Stock | 11,794 footnote F1 | $5.12 | $60K | |
| Leslie Trigg - Officer | Open-market sale | Common Stock | 2,120 footnote F1 | $5.05 | $11K | |
| ||||||
| Karen Drexler - Director | Open-market sale | Common Stock | 1,548 | $4.37 | $7K | |
| Marc Nash - Officer | Open-market sale | Common Stock | 247 footnote F1 | $4.60 | $1K | |
| ||||||
| John L. Brottem - Officer | Open-market sale | Common Stock | 388 footnote F1 | $4.60 | $2K | |
| ||||||
| Leslie Trigg - Officer | Open-market sale | Common Stock | 916 footnote F1 | $4.60 | $4K | |
| ||||||
Item 5.02
Item 2.02, 9.01
Item 1.01, 2.02, 9.01
Item 5.07
Recent OM Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Trigg Leslie | Officer | 3,344 | $15K | View on EDGAR | |
| Gaeta Renee | Officer | 4,422 | $20K |
OM insider trading FAQ
What is the latest insider trade for OM?
Outset Medical, Inc. (OM) had 4 insider filings in the last 90 days, with the most recent on 2026-10-05. The full record for OM runs to 44 Form 4 filings, the earliest from 2024-11-18. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying OM stock?
2 insider purchases of OM were filed in the last 90 days, totaling $870K.
How many insiders are selling OM stock?
3 insider sales of OM were filed in the last 90 days, totaling $47K.
Where can I see OM SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects OM Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Braden Michael Leonard view on EDGAR
- - Leslie Trigg view on EDGAR
- - John L. Brottem view on EDGAR
- - Renee Gaeta view on EDGAR
- - John L. Brottem view on EDGAR
- - Renee Gaeta view on EDGAR
- - Leslie Trigg view on EDGAR
- - Patrick T. Hackett view on EDGAR
- - Kevin C. Oboyle view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where OM's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow OM with a 7-day demo
- OM on your watchlist
- Every OM Form 4 filing on record
- Up to 3 months of OM price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
